news
Streptococcal toxic shock syndrome vaccine candidate developed
Researchers have created a vaccine to treat and prevent streptococcal toxic shock syndrome which showed success in mice models.
List view / Grid view
Monoclonal Antibody
whitepaper
Application note: Rapidly isolate high-producing clones
Find out how to streamline Cell Line Development by identifying high-producing clones with monoclonality assurance in one day.
article
Antibodies In-Depth Focus 2018
In this In-Depth Focus, Stefan R. Schmidt discusses the current status and future perspectives of monoclonal antibodies and Tony Edge explains why the determination of aggregate is critical in the formation of monoclonal antibodies.
news
Targeting BAFF reduces the development of atherosclerosis
The researchers identified that BAFF to have anti-inflammatory properties, which has a positive effect on plaque size and atherosclerosis...
news
Kymab appoints Dr Sonia Quaratino as Chief Medical Officer
Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Sonia Quaratino as its first Chief Medical Officer. Dr Quaratino will manage the clinical development of the Group's expanding therapeutic antibody portfolio.
